Innoveren Scientific, Inc. Quarterly Debt-to-equity in % from Q3 2015 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Innoveren Scientific, Inc. quarterly Debt-to-equity history and growth rate from Q3 2015 to Q3 2023.
  • Innoveren Scientific, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -104 %, a 2.94% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -104 +3.14 +2.94% Sep 30, 2023
Q2 2023 -102 +8.26 +7.47% Jun 30, 2023
Q1 2023 -103 +19.8 +16.1% Mar 31, 2023
Q4 2022 -105 +22 +17.3% Dec 31, 2022
Q3 2022 -107 +45.6 +30% Sep 30, 2022
Q2 2022 -111 Jun 30, 2022
Q1 2022 -123 Mar 31, 2022
Q4 2021 -127 Dec 31, 2021
Q3 2021 -152 Sep 30, 2021
Q4 2019 111 +249 Dec 31, 2019
Q3 2019 95.3 +674 Sep 30, 2019
Q2 2019 124 -11.7 -8.66% Jun 30, 2019
Q1 2019 757 +680 +880% Mar 31, 2019
Q4 2018 -138 -175 -473% Dec 31, 2018
Q3 2018 -579 -660 -815% Sep 30, 2018
Q2 2018 135 +12 +9.7% Jun 30, 2018
Q1 2018 77.3 -36.5 -32.1% Mar 31, 2018
Q4 2017 37 -4.4 -10.6% Dec 31, 2017
Q3 2017 80.9 +61 +306% Sep 30, 2017
Q2 2017 123 +113 +1052% Jun 30, 2017
Q1 2017 114 +106 +1305% Mar 31, 2017
Q4 2016 41.4 +33.4 +417% Dec 31, 2016
Q3 2016 19.9 +13.8 +226% Sep 30, 2016
Q2 2016 10.7 Jun 30, 2016
Q1 2016 8.1 Mar 31, 2016
Q4 2015 8.02 Dec 31, 2015
Q3 2015 6.11 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.